⌘K

MyMD Pharmaceuticals, Inc. (MYMD)

$1.81 -0.55% $-0.01 Healthcare

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines; and to delay aging and increase longevity, as well as treat autoimmune diseases and COVID-19-associated depression. It is also developing Supera-CBD, a synthetic derivative of cannabidiol for treating chronic pain, addiction, and epilepsy. The company was founded in 2014 and is headquartered in Baltimore, Maryland.

Market cap

$4.29M

CEO

Dr. Christopher C. Chapman Jr., M.D.

Full time employees

9.00

Headquarters

Baltimore, MD

IPO Date

Jul 24, 2008

Price-to-earnings (PE) Ratio

-0.20

Earnings-per-share (EPS)

$-9.27

Cash ratio (TTM)

0.06

Current ratio (TTM)

0.62

Net profit margin (TTM)

0.00%

PE ratio (TTM)

-0.32

PEG ratio (TTM)

-0.00

Price-to-book ratio (TTM)

0.38

Price-to-sales ratio (TTM)

0.00

Quick ratio (TTM)

0.62

Return on assets (TTM)

-84.78%

Return on equity (TTM)

-98.57%

Similar stocks (22)

Keros Therapeutics, Inc.

KROS

$57.03 2.37% $1.32

Neutral

Recursion Pharmaceuticals, Inc.

RXRX

$7.10 2.75% $0.19

Downtrend

Ligand Pharmaceuticals Incorporated

LGND

$105.67 1.92% $1.99

Uptrend

ORIC Pharmaceuticals, Inc.

ORIC

$12.00 12.46% $1.33

Neutral

Replimune Group, Inc.

REPL

$11.42 3.02% $0.34

Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.32 6.93% $0.48

Downtrend

Lyell Immunopharma, Inc.

LYEL

$1.54 14.39% $0.20

Downtrend

Atea Pharmaceuticals, Inc.

AVIR

$3.94 -1.13% $-0.04

Neutral

Design Therapeutics, Inc.

DSGN

$5.80 2.84% $0.16

Uptrend

Gossamer Bio, Inc.

GOSS

$0.94 2.99% $0.03

Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.87 2.54% $0.17

Downtrend

Kronos Bio, Inc.

KRON

$0.95 3.23% $0.03

Downtrend

Passage Bio, Inc.

PASG

$0.70 0.29% $0.00

Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.57% $0.00

Downtrend

Surrozen, Inc.

SRZN

$8.10 1.12% $0.09

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 3.57% $0.02

Downtrend

Unity Biotechnology, Inc.

UBX

$1.45 2.11% $0.03

Downtrend

GeoVax Labs, Inc.

GOVX

$2.86 6.30% $0.17

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.29% $0.00

Downtrend

Xenetic Biosciences, Inc.

XBIO

$3.65 0.00% $0.00

Downtrend

Revelation Biosciences, Inc.

REVB

$0.87 0.46% $0.00

Downtrend

NovaBay Pharmaceuticals, Inc.

NBY

$0.51 0.00% $0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend

Downtrend

Similar stocks (22)

Keros Therapeutics, Inc.

KROS

$57.03 2.37% $1.32

Neutral

Recursion Pharmaceuticals, Inc.

RXRX

$7.10 2.75% $0.19

Downtrend

Ligand Pharmaceuticals Incorporated

LGND

$105.67 1.92% $1.99

Uptrend

ORIC Pharmaceuticals, Inc.

ORIC

$12.00 12.46% $1.33

Neutral

Replimune Group, Inc.

REPL

$11.42 3.02% $0.34

Uptrend

Larimar Therapeutics, Inc.

LRMR

$7.32 6.93% $0.48

Downtrend

Lyell Immunopharma, Inc.

LYEL

$1.54 14.39% $0.20

Downtrend

Atea Pharmaceuticals, Inc.

AVIR

$3.94 -1.13% $-0.04

Neutral

Design Therapeutics, Inc.

DSGN

$5.80 2.84% $0.16

Uptrend

Gossamer Bio, Inc.

GOSS

$0.94 2.99% $0.03

Downtrend

Nuvectis Pharma, Inc.

NVCT

$6.87 2.54% $0.17

Downtrend

Kronos Bio, Inc.

KRON

$0.95 3.23% $0.03

Downtrend

Passage Bio, Inc.

PASG

$0.70 0.29% $0.00

Downtrend

Kezar Life Sciences, Inc.

KZR

$0.58 0.57% $0.00

Downtrend

Surrozen, Inc.

SRZN

$8.10 1.12% $0.09

Downtrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 3.57% $0.02

Downtrend

Unity Biotechnology, Inc.

UBX

$1.45 2.11% $0.03

Downtrend

GeoVax Labs, Inc.

GOVX

$2.86 6.30% $0.17

Downtrend

Lyra Therapeutics, Inc.

LYRA

$0.28 2.29% $0.00

Downtrend

Xenetic Biosciences, Inc.

XBIO

$3.65 0.00% $0.00

Downtrend

Revelation Biosciences, Inc.

REVB

$0.87 0.46% $0.00

Downtrend

NovaBay Pharmaceuticals, Inc.

NBY

$0.51 0.00% $0.00

Downtrend

ETF Exposure (2)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$136.02 0.03% $0.04

Uptrend

Vanguard Extended Market Index Fund

VXF

$182.71 1.88% $3.37

Uptrend